Clinical trial NCT02551965: Nursing Follow up in Geriatric Oncology : Tracking Time of Caregiver Exhaustion Risk
Official title: Nursing Follow up in Geriatric Oncology : Tracking Time of Caregiver Exhaustion Risk
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Exhaustion
Geriatric Disorder
Keywords: Cancer
Patient
Oncology
Caregiver
Lead sponsor: University Hospital, Strasbourg, France
Sponsor class: OTHER
First posted: 2015-09-16
Enrollment: 200
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: In geriatric oncology, caregivers are submitted to a risk of exhaustion. To investigate the clinical risk factor of exhaustion, the researchers propose to conduct a prospective observational study during 6 months phone follow up of the caregivers. The recruitment will take place during the oncogeriatric assessment consultation.

Detailed description: The primary purpose aim to describe the caregiver of patient with 70 years old or more, suffered from cancer and for which a treatment is planned, along with their long term evolution.

The secondary purposes are to :

* Assess the exhaustion level felt by this caregiver
* Assess the medium delay of caregiver exhaustion apparition
* Relate factors associated to the medium delay of caregiver exhaustion apparition during patient chemotherapy and/or radiotherapy treatment

Eligibility criteria: Inclusion Criteria:

* Caregiver of :

  * patient with 70 years old or more, suffered from cancer and receiving specific cancer treatment (chemotherapy or radiotherapy )
  * Patient evaluated in a specific comprehensive oncogeriatric assessment
  * informed patient given a non-opposition form
  * Patient affiliated to a social protection scheme
* Informed consent given by the caregiver

Exclusion Criteria:

* Patient and caregiver under judicial protection
* Caregiver with understanding difficulties with French language
* Psychological, familial, social or geographic conditions that avoid a good clinical trial continuity
* Patient with ≤ 18 years old
* Caregiver and patient with significant cognitive troubles
* Caregiver and patient located in institution during inclusion period

Primary outcomes:
measure: Standard collection of sociodemographic caregivers features
timeFrame: 6 months
measure: Standard collection of economic caregivers features
timeFrame: 6 months
measure: Standard collection of physical health caregivers features
timeFrame: 6 months
measure: Standard collection of psychological health caregivers features
timeFrame: 6 months
measure: Standard collection of caregivers support frequency
timeFrame: 6 months
Secondary outcomes:
measure: The exhaustion level felt by caregiver is assessed with Mini-Zarit scale
timeFrame: 6 months
measure: Medium delay of caregiver exhaustion apparition is assessed with Mini-Zarit scale
timeFrame: 6 months
measure: Factors associated with medium delay of caregiver exhaustion apparition are determined with caregiver and patient features
timeFrame: 6 months
Other outcomes:
Locations:
city: Strasbourg
country: France
facility: Unité de Coordination Régionale en Oncogériatrie - Hôpital de Hautepierre
Study officials:
affiliation: Strasbourg's University Hospitals - UCROG
name: Damien HEITZ, MD
role: PRINCIPAL_INVESTIGATOR
References: